Cardiac biomarkers: When to test? - physician perspective

Journal, Indian Academy of Clinical Medicine

Volumn 12, Issue 2, 2011, Pages 117-121

  Singh, T P ^a   Nigam, A K ^a   Gupta, A K ^a   Singh, B ^a  

^a S N MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; MYELOPEROXIDASE; MYOGLOBIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; DIAGNOSTIC VALUE; HUMAN; LABORATORY DIAGNOSIS; PROTEIN DETERMINATION; REVIEW;

EID: 79960040888     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Antman EM, Hand M, Armstrong PW et al. 2007 Focused update of the ACC/AHA 2004. Guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 2008; 117 (2): 296-329.
2. Nichols JH, Christenson RH, Clarke W et al. Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. Clin Chim Acta 2007; 379 (1-2): 14-28.
3. Kavsak PA, MacRae AR, Newman AM et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CK-MB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta 2007; 380 (1- 2): 213-216.
4. Saenger AK, Jaffe AS. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation 2008; 118 (21): 2200-2206.
5. Reichlint, Hochholzerw, Basseltis et al. Early diagnosis of myocardial infarction with sensitive cardiac troponins assay. N Eng J Med 2009; 361 (9): 858-867.
6. Antman EM, Tanasijevic MJ, Thompson B et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335 (18): 1342-1349.
7. Newby LK, Christenson RH, Ohman EM et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 1998; 98 (18): 1853-1859.
8. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996; 93 (9): 1651-1657.
9. Apple FS, Falahati A, Paulsen PR et al. Improved detection of minor ischaemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem 1997; 43 (11): 2047-2051.
10. Morrow DA, Cannon CP, Rifai N et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomised trial. JAMA 2001; 286 (19): 2405-2412.
11. Apple FS, Murakami MA. The diagnostic utility of cardiac biomarkers in detecting myocardial infarction. Clin Cornerstone 2005; 7 (suppl 1): 525-530.
12. Zimmerman J, Fromm R, Meyer D et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999; 99 (13): 1671-1677.
13. Puleo PR, Meyer D, Wathen C et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule-out acute myocardial infarction. N Engl J Med 1994; 331 (9): 561-566.
14. Eggers KM, Oldgren J, Nordenskjold A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004; 148 (4): 574-581.
15. Koenig W. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol 2005; 98 (2): 199-206.
16. de Lemos JA, Morrow DA, Bentley JH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345 (14): 1014-1021.
17. Sabatine MS, Morrow DA, de Lemos JA et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischaemia. J Am Coll Cardiol 2004; 44 (10): 1988-1995.
18. Morrow DA, de Lemos JA, Sabatine MS et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-STelevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003; 41 (8): 1264-1272.
19. Brennar ML, penn MS, Van lente F et al. Prognostic value of myeloperoxidase in patients with chest pain. N Eng J Med 2003; 349: 1595-1605 (PMID: 14573731).
20. Peacock F, Morris DL, Anwaruddin S et al. Meta-analysis of ischaemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006; 152 (2): 253-262.
21. Sinha MK, Roy D, Gaze DC et al. Role of "Ischaemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21 (1): 29-34.
22. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-elevation myocardial infarction. J Am Coll Cardiol 2007; 50 (7): 1-157.